The Dynamics of Heparin-Binding Protein in Cardiothoracic Surgery-A Pilot Study.
biomarker
cardiopulmonary bypass
cardiothoracic surgery
heparin-binding protein
postoperative infections
Journal
Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
01
10
2020
revised:
16
12
2020
accepted:
18
12
2020
pubmed:
18
1
2021
medline:
26
10
2021
entrez:
17
1
2021
Statut:
ppublish
Résumé
To explore the preoperative, intraoperative, and postoperative dynamics of heparin-binding protein (HBP) in cardiothoracic surgery. This was a prospective, observational study. The study was conducted at a single university hospital. Thirty patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) were included, 15 of whom underwent coronary artery bypass grafting surgery and 15 of whom underwent complex procedures. Ten patients undergoing lung surgery also were included as a conventional surgery reference group. No interventions were performed. HBP was measured at nine different perioperative times. HBP levels increased immediately after heparin administration, further increased during CPB, but decreased rapidly after protamine administration. At arrival to the intensive care unit, median HBP levels were 24.8 (15.6-38.1) ng/mL for coronary artery bypass grafting patients and 51.2 (34.0-117.7) ng/mL for complex surgery patients (p = 0.011). One day after surgery, HBP levels in all three groups were below the proposed cutoff of 30 ng/mL, which previously was found to predict development of organ dysfunction in patients with infection. HBP levels are elevated by the administration of heparin and the use of CPB but reduced by protamine administration. At postoperative day one, HBP levels were less than the threshold for organ dysfunction in patients with infection. The usefulness of HBP for predicting postoperative infections in cardiothoracic surgery should be investigated in future studies.
Identifiants
pubmed: 33454168
pii: S1053-0770(20)31380-X
doi: 10.1053/j.jvca.2020.12.033
pii:
doi:
Substances chimiques
AZU1 protein, human
0
Antimicrobial Cationic Peptides
0
Blood Proteins
0
Heparin
9005-49-6
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2640-2650Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.